Overview

Intramuscular Ketamine Effect on Postnasal Surgery Agitation

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Randomized study of ASA I-II patients, who will undergo elective nasal surgery( septoplasty and septorhinoplasty ) . The patients will be randomly divided into 2 groups: ketamine (group-K) and saline (control group) (group-S). At the time of turning the inhalational agent off , intramuscular racemic ketamine will be administered in a dose of 0.7 mg/kg, whereas group-s will receive intramuscular saline with same volume that would be administered if it was ketamine. Sedation and Agitation scores were recorded using The Richmond agitation-sedation score after extubation.
Phase:
Phase 2
Details
Lead Sponsor:
Jordanian Royal Medical Services
Treatments:
Ketamine